PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

FDA review on transgenic salmon too narrow

2010-11-19
(Press-News.org) DURHAM, N.C. -- The review process being used by the Food and Drug Administration to assess the safety of a faster-growing transgenic salmon fails to weigh the full effects of the fish's widespread production, according to analysis by a Duke University-led team in this week's Science.

The salmon, whose genome contains inserted genes from two other fish species, could become the first genetically modified animal approved for human consumption in the United States.

The FDA held two days of hearings in September to assess the fish's human and environmental health risks. The period for public comment ends this month. A final FDA decision could be imminent.

The concern, Duke economist Martin D. Smith says, is that the new animal drug application process FDA is using to review the transgenic salmon evaluates its safety only by comparing its nutritional profile to an equivalent portion of nonmodified salmon, and screening it for known toxins and allergens.

Smith said such a process ignores the potential health and environmental effects of salmon production and consumption -- both positive and negative -- that might stem from the fish's faster growth and less need for feed.

"These market impacts could dwarf any small differences in nutritional content," says Smith, associate professor of environmental economics at Duke's Nicholas School of the Environment.

A smarter approach, Smith and his coauthors argue, would be for FDA – or if necessary, Congress – to broaden the interpretation of the terms "safe" and "health" in FDA statutes so its review process can include an evaluation of the overall safety of the new fish compared to other protein sources that it might replace, such as beef.

"Instead of focusing on the safety of a food taken one portion at a time or whether it was produced through genetic modifications or through classic breeding, a more useful approach would be to evaluate whether society is better off overall with the new product on the market than without it," says Jonathan B. Wiener, William R. and Thomas L. Perkins Professor of Law at Duke Law School.

This fuller assessment would require FDA regulators to take into consideration factors currently unaccounted for, such as public health impacts that could occur if, as is likely, increased production of transgenic farmed salmon leads to lower retail prices and increased consumption.

"Lower prices for salmon would have significant public health benefits," Smith explained. "Consumers would have access to a less expensive source of healthy protein and omega-3 fatty acids, which have well-documented health benefits."

A broader review would also allow a fuller assessment of potential environmental impacts, such as pollution from farmed salmon waste; disease; increased harvesting of the wild fish used to feed farmed salmon; and the escape of genetically modified salmon into the wild, where they could affect wild salmon stocks through gene transfer or increased competition for resources.

The National Environmental Policy Act mandates FDA to assess significant environmental impacts from market expansion of the products it approves, yet the narrow scope of the current review process for new animal drugs presents "an incomplete picture" of these risks and benefits for transgenic salmon, the researchers write in their analysis.

"The approval of genetically modified salmon will set an important precedent for other transgenic animals intended for human consumption," Smith says. "It's essential that FDA establishes an approval process that assesses the full portfolio of impacts to ensure that such decisions serve society's best interests." FDA administrators need to weigh the benefits of such assessments against the costs and delays they likely would incur, he says.

If conducting a full assessment of transgenic salmon would take too long, a reasonable compromise would be to use existing studies to develop scenarios of market growth and the broader impacts to human and environmental health that may occur as a result.

INFORMATION: Frank Asche of the University of Stavanger, Norway, and Atle G. Guttormsen of the Norwegian University of Life Sciences co-authored the Science paper with Smith and Wiener.

Smith also holds a faculty position in Duke's Department of Economics. Wiener also holds faculty appointments as professor of environmental policy at the Nicholas School, and professor of public policy at Duke's Sanford School of Public Policy.



ELSE PRESS RELEASES FROM THIS DATE:

It takes a village: Mechanism alerts neighbors to amplify immune response

2010-11-19
The pathogen Shigella flexneri invades the cells that line the gut and causes Shigellosis, a disorder characterized by diarrhea and sometimes even death in humans. S. flexneri subverts the normal immune response of the host by interfering with the ability of the infected cell to secrete chemicals called chemokines that stimulate inflammation. Inflammation is a complex response to pathogens that attracts white blood cells to destroy the bacteria. Despite the documented ability of S. flexneri to suppress inflammation in infected cells, intestinal cells do secrete large amounts ...

Researchers uncover surprise link between weird quantum phenomena

Researchers uncover surprise link between weird quantum phenomena
2010-11-19
Researchers have uncovered a fundamental link between the two defining properties of quantum physics. Stephanie Wehner of Singapore's Centre for Quantum Technologies and the National University of Singapore and Jonathan Oppenheim of the United Kingdom's University of Cambridge published their work today in the latest edition of the journal Science. The result is being heralded as a dramatic breakthrough in our basic understanding of quantum mechanics and provides new clues to researchers seeking to understand the foundations of quantum theory. The result addresses the ...

Panama Canal, Panama City at risk of large earthquake, says new research

2010-11-19
Panama Canal, PanNew data suggest that the Limon and Pedro Miguel faults in Central Panama have ruptured both independently and in unison over the past 1400 years, indicating a significant seismic risk for Panama City and the Panama Canal, according to research published today by the Bulletin of the Seismological Society of America (BSSA). The Panama Canal is undergoing expansion to allow for greater traffic of larger ships, scheduled for completion by 2014. As part of a seismic hazard characterization for the Panama Canal Authority (ACP) expansion project, Rockwell, ...

Planet from another galaxy discovered

Planet from another galaxy discovered
2010-11-19
Over the last 15 years, astronomers have detected nearly 500 planets orbiting stars in our cosmic neighbourhood, but none outside our Milky Way has been confirmed [1]. Now, however, a planet with a minimum mass 1.25 times that of Jupiter [2] has been discovered orbiting a star of extragalactic origin, even though the star now finds itself within our own galaxy. It is part of the so-called Helmi stream — a group of stars that originally belonged to a dwarf galaxy that was devoured by our galaxy, the Milky Way, in an act of galactic cannibalism about six to nine billion years ...

Paleovirology expanded: Non-retroviral virus fragments found in animal genomes

2010-11-19
Understanding the evolution of life-threatening viruses like influenza, Ebola and dengue fever, could help us to minimize their impact. New research points the way to a fossil record of viruses that have insinuated themselves into the genomes of insects and other animals, providing clues about their evolutionary history. The findings, published online on November 18 in the open-access journal PLoS Genetics, could enable scientists to elucidate general principles in virus evolution from their genetic "fossils", which in turn could inform approaches for controlling disease. Robert ...

Scripps Research scientists report molecular structure of dopamine receptor

2010-11-19
LA JOLLA, CA – November 16, 2010 – A team led by scientists at The Scripps Research Institute has solved the structure of one of the receptors that responds to the neurotransmitter dopamine. Although dopamine transmission is essential to normal brain functioning, the biological assembly of the molecules involved in this crucial neuronal interplay had not been known—until now. The work was reported in the November 19, 2010, issue of the journal Science. In the new study, whose authors included collaborators from Weill Cornell Medical College, Receptos, the National Institute ...

Paw prints and feces offer new hope for saving tigers

Paw prints and feces offer new hope for saving tigers
2010-11-19
As experts gather in St Petersburg, Russia for next week's Tiger Summit, fewer than 3,200 tigers survive in the wild worldwide. More than half live in India, where they are spread over a vast area (100,000 sq km) of forest. According to Dr Yadvendradev Jhala of the Wildlife Institute of India, lead author of the new study: "Tigers are cryptic, nocturnal and occur at low densities so they are extremely difficult to monitor. Unless we know how many tigers are left in the wild, and whether their numbers are increasing or decreasing, we will not be able to conserve them." Until ...

Cough medicine could help doctors identify how breast cancer patients metabolize tamoxifen

2010-11-19
Cough medicine could be used as way of predicting how well individual patients metabolise tamoxifen used in the treatment of their breast cancer, according to new research presented at the 22nd EORTC-NCI-AACR [1] Symposium on Molecular Targets and Cancer Therapeutics in Berlin today (Friday). The findings suggest that it could be possible to use cough suppressant syrup as a probe, which would enable doctors to identify patients with altered metabolism and use this information to improve individual treatment, making it more effective and reducing the chances of side-effects. ...

Researchers find new target for stopping tumors developing their own blood supply

2010-11-19
Researchers have found that a newly developed drug, which is aimed at a particular receptor involved in the development of blood vessels that sustain tumour growth, is active in patients with advanced cancers and, in some cases, has halted the progress of the disease. The drug, ACE-041, targets a different molecular pathway to other anti-angiogenesis drugs and may provide a new option to treat cancer. Results from a phase I clinical study of ACE-041 were presented at the 22nd EORTC-NCI-AACR [1] Symposium on Molecular Targets and Cancer Therapeutics in Berlin today (Friday). ...

UCLA team uncovers mechanism behind organ transplant rejection

UCLA team uncovers mechanism behind organ transplant rejection
2010-11-19
UCLA researchers have pinpointed the culprit behind chronic rejection of heart, lung and kidney transplants. Published in the Nov. 23 edition of Science Signaling, their findings suggest new therapeutic approaches for preventing transplant rejection and sabotaging cancer growth. The team focused on the mechanism behind narrowing of the donor's grafted blood vessels, which blocks blood from reaching the transplanted organ. Starved of oxygen and other nutrients, the organ eventually fails, forcing the patient back on the transplant waiting list. "Chronic rejection ...

LAST 30 PRESS RELEASES:

Metformin changes blood metal levels in humans

Long-term anticoagulation discontinuation after catheter ablation for atrial fibrillation

Fractional flow reserve–guided complete vs culprit-only revascularization in non–ST-elevation myocardial infarction and multivessel disease

Participation of women in cardiovascular trials from 2017 to 2023

Semaglutide and tirzepatide in patients with heart failure with preserved ejection fraction

Changes in biology of internal fat may be the leading cause of heart failure

Transcatheter or surgical treatment of patients with aortic stenosis at low to intermediate risk

Promising new drug for people with stubborn high blood pressure

One shot of RSV vaccine effective against hospitalization in older adults for two seasons

Bivalent RSV prefusion F protein–based vaccine for preventing cardiovascular hospitalizations in older adults

Clonal hematopoiesis and risk of new-onset myocarditis and pericarditis

Risk of myocarditis or pericarditis with high-dose vs standard-dose influenza vaccine

High-dose vs standard-dose influenza vaccine and cardiovascular outcomes in older adults

Prevalence, determinants, and time trends of cardiovascular health in the WHO African region

New study finds that, after a heart attack, women have worse prognosis when treated with beta-blockers

CNIC-led REBOOT clinical trial challenges 40-year-old standard of care for heart attack patients

Systolic blood pressure and microaxial flow pump–associated survival in infarct-related cardiogenic shock

Beta blockers, the standard treatment after a heart attack, may offer no benefit for heart attack patients and women can have worse outcomes

High Mountain Asia’s shrinking glaciers linked to monsoon changes

All DRII-ed up: How do plants recover after drought?

Research on stigma says to just ‘shake it off’

Scientists track lightning “pollution” in real time using NASA satellite

Millions of women rely on contraceptives, but new Rice study shows they may do more than just prevent pregnancy

Hot days make for icy weather, Philippine study finds

Roxana Mehran, MD, receives the most prestigious award given by the European Society of Cardiology

World's first clinical trial showing lubiprostone aids kidney function

Capturing language change through the genes

Public trust in elections increases with clear facts

Thawing permafrost raised carbon dioxide levels after the last ice age

New DNA test reveals plants’ hidden climate role

[Press-News.org] FDA review on transgenic salmon too narrow